CRESEMBA
CRESEMBA
Approved
DIN Number
02483971
Drug Class
Human
Market Date
May 2, 2019
Company
HC
avir pharma inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02483971
AIG Number0161030001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J02AC05 ISAVUCONAZOLE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification08:14.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
ISAVUCONAZOLE (ISAVUCONAZONIUM SULFATE)Active
Strength: 100 MG
Monograph: ISAVUCONAZOLE (ISAVUCONAZONIUM SULFATE)